CoChat

Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling

Open access

The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index.

Abstract

The Nedd4-1 E3 Ubiquitin ligase has been implicated in multiple disease conditions due its overexpression. Although the enzyme may be targeted both covalently and non-covalently, minimal studies provide effective inhibitors against it. Recently, research has focused on covalent inhibitors based on their characteristic, highly-selective warheads and ability to prevent drug resistance. This prompted us to screen for new covalent inhibitors of Nedd4-1 using a combination of computational approaches. However, this task proved challenging due to the limited number of electrophilic moieties available in virtual libraries. Therefore, we opted to divide an existing covalent Nedd4-1 inhibitor into two parts: a non-covalent binding group and a pre-selected α, β-unsaturated ester that forms the covalent linkage with the protein. A non-covalent pharmacophore model was built based on molecular interactions at the binding site. The pharmacophore was then subjected to virtual screening to identify structurally similar hit compounds. Multiple filtrations were implemented prior to selecting four hits, which were validated with a covalent conjugation and later assessed by molecular dynamic simulations. The results showed that, of the four hit molecules, Zinc00937975 exhibited advantageous molecular groups, allowing for favourable interactions with one of the characteristic cysteine residues. Predictive pharmacokinetic analysis further justified the compound as a potential lead molecule, prompting its recommendation for confirmatory biological evaluation. Our inhouse, refined, pharmacophore model approach serves as a robust method that will encourage screening for novel covalent inhibitors in drug discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules24173125

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mechanism of the covalent binding to the allosteric cysteine of Nedd4-1. a Non-covalent binding part of the inhibitor. b Covalent warhead of the inhibitor (α, β-unsaturated ester). c Allosteric cysteine (Cys627) of the Nedd4-1. d Intermediate product of the reaction. e Product of the reaction.
Figure 1 Mechanism of the covalent binding to the allosteric cysteine of Nedd4-1. a Non-covalent binding part of the inhibitor. b Covalent warhead of the inhibitor (α, β-unsaturated ester). c Allosteric cysteine (Cys627) of the Nedd4-1. d Intermediate product of the reaction. e Product of the reaction.CC BY · PubMed Central
Figure 2 Important pharmacophoric features of the inhibitor’s non-covalent part and generation of a pharmacophore model based on these features.
Figure 2 Important pharmacophoric features of the inhibitor’s non-covalent part and generation of a pharmacophore model based on these features.CC BY · PubMed Central
Figure 3 Outline of computational protocol and implemented filters.
Figure 3 Outline of computational protocol and implemented filters.CC BY · PubMed Central
Figure 4 C-a backbone RMSD (Root-Mean-Square Deviation) plots of the four compounds in complex with Nedd4-1 when compared with the Apo enzyme.
Figure 4 C-a backbone RMSD (Root-Mean-Square Deviation) plots of the four compounds in complex with Nedd4-1 when compared with the Apo enzyme.CC BY · PubMed Central
Figure 5 The RMSF plots of the four compounds in complex with Nedd4-1 in comparison with the Apo enzyme.
Figure 5 The RMSF plots of the four compounds in complex with Nedd4-1 in comparison with the Apo enzyme.CC BY · PubMed Central
Figure 6 Per-residue decomposition analyses revealing individual energy contributions of allosteric site residues to the binding and stability of original compound and compounds 1–4. Residues contributing the most to binding of all four compounds included TYR 87, TYR 88, and CYS 110.
Figure 6 Per-residue decomposition analyses revealing individual energy contributions of allosteric site residues to the binding and stability of original compound and compounds 1–4. Residues contributing the most to binding of all four compounds included TYR 87, TYR 88, and CYS 110.CC BY · PubMed Central
Figure 7 Sequence alignment of the nine members of the Nedd4 family.
Figure 7 Sequence alignment of the nine members of the Nedd4 family.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Bethesda (MD): National Library of Medicine (US) (2018, March 11). National Center for Biotechnology Information (NCBI), Available online: https://www.ncbi.nlm.nih.gov/.

Cited by

See all 6

Metadata

Authors
Bjij, I., Ramharack, P., Khan, S., Cherqaoui, D., & Soliman, M. E. S.
Affiliations
  • Cadi Ayyad University (MA)
  • University of KwaZulu-Natal (ZA)
  • University of the Witwatersrand (ZA)
Corresponding author
Soliman, Mahmoud E. S.
Venue
Molecules
Publisher
MDPI AG
Published
2019-08-28
Volume
24
Issue
17
Pages
3125
ISSN
1420-3049 (ISSN-L)
OpenAlex
W2970088476
Cited by
6
References
35
Citations by year
2026: 1 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 2
FWCI
0.68
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
College of Health Sciences, University of KwaZulu-Natal (N/A)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
Keywords
NEDD4-1, E3 ubiquitin ligase, covalent inhibitors, pharmacophore modeling, virtual screening, α,β-unsaturated esters, electrophilic warheads, cysteine residues, drug resistance, molecular dynamics simulation
MeSH terms
Binding Sites, Computer Simulation, Cysteine, Enzyme Inhibitors, Humans, Hydrogen Bonding, Models, Molecular, Structure-Activity Relationship, Molecular Structure, Ubiquitin-Protein Ligases, Drug Discovery, Molecular Dynamics Simulation, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.